Vincent Milano

Board Member · BIOCRYST PHARMACEUTICALS INC

Rank #27,923 SEC EDGAR (United States) ↗

Details

Member of the boardPharmaceuticals & BiotechnologyBCRXSEC CIK 0001187159

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$1.0M
1-day change
▼ 0.79%
Positions on file
2
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 2 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$643.3K – $1.1M2026-09-04

Insider activity May 20, 2024 – Feb 27, 2026

Vincent Milano is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 13 transactions between May 20, 2024 and Feb 27, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
$93.8K
1 purchase on file priced rows only
Open-market sales (code S)
None
0 sales on file
All reported transactions
13
every code, including awards and exercises
Pattern
Bought and sold in similar amounts
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 17 most recent rows are grouped into 17 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 1,159 shares $11.2K at $9.70 SEC filing ↗
  2. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decisionreported at zero 15,294 shares $0 at $0.00 SEC filing ↗
  3. Aclaris Therapeutics, Inc. ACRS M Option exercise or conversionnot a buy/sell decisionreported at zero 11,580 shares $0 at $0.00 SEC filing ↗
  4. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 1,122 shares $10.0K at $8.91 SEC filing ↗
  5. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 848 shares $7.4K at $8.75 SEC filing ↗
  6. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 783 shares $5.6K at $7.18 SEC filing ↗
  7. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 676 shares $5.6K at $8.31 SEC filing ↗
  8. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decisionreported at zero 12,500 shares $0 at $0.00 SEC filing ↗
  9. Aclaris Therapeutics, Inc. ACRS M Option exercise or conversionnot a buy/sell decisionreported at zero 4,793 shares $0 at $0.00 SEC filing ↗
  10. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 523 shares $5.6K at $10.75 SEC filing ↗
  11. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 653 shares $5.6K at $8.61 SEC filing ↗
  12. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 750 shares $5.6K at $7.50 SEC filing ↗
  13. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 647 shares $5.6K at $8.69 SEC filing ↗
  14. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decisionreported at zero 6,820 shares $0 at $0.00 SEC filing ↗
  15. Aclaris Therapeutics, Inc. ACRS M Option exercise or conversionnot a buy/sell decisionreported at zero 4,660 shares $0 at $0.00 SEC filing ↗
  16. BIOCRYST PHARMACEUTICALS INC BCRX A Grant or awardnot a buy/sell decision 870 shares $5.6K at $6.46 SEC filing ↗
  17. BIOCRYST PHARMACEUTICALS INC BCRX P Open-market purchase 15,000 shares $93.8K at $6.25 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
BIOCRYST PHARMACEUTICALS INC BCRX Common Stock 92,067 $9.96 $917.0K 4 EDGAR ↗
Aclaris Therapeutics, Inc. ACRS Common Stock 17,316 $6.17 $106.8K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Vincent Milano reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.